In ovo inhibition of steroid metabolism by bisphenol-A as a potential mechanism of endocrine disruption

Proceedings of the Royal Society B: Biological Sciences

Volumn 280, Issue 1769, 2013, Pages

  Clairardin, Sandrine G ^a   Paitz, Ryan T ^a   Bowden, Rachel M ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

Oestradiol; Oestrone sulfate; Steroid metabolism

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; DRUG ADMINISTRATION; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN; PHENOL DERIVATIVE;

ALCOHOL; EMBRYONIC DEVELOPMENT; ENDOCRINE DISRUPTOR; INHIBITION; METABOLISM; PHENOL; PHENOTYPE; SIGNALING; STEROID; TURTLE;

ANIMAL; ANIMAL EMBRYO; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; LIQUID CHROMATOGRAPHY; METABOLISM; OOCYTE; RANDOMIZATION; TANDEM MASS SPECTROMETRY; TOXICITY; TURTLE; UNITED STATES;

ADMINISTRATION AND DOSAGE; ANIMALS; BENZHYDRYL COMPOUNDS; CHROMATOGRAPHY, LIQUID; DRUG EFFECTS; EMBRYO, NONMAMMALIAN; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGENS; FEMALE; GROWTH AND DEVELOPMENT; ILLINOIS; METABOLISM; OVUM; PHENOLS; RANDOM ALLOCATION; TANDEM MASS SPECTROMETRY; TOXICITY; TURTLES;

EID: 84892567778     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2013.1773     Document Type: Article

References (54)

1. Arnold AP. 2009 The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55, 570-578. (doi:10.1016/j.yhbeh. 2009.03.011)
2. Norris DO. 2007 Vertebrate endocrinology, 4th edn. San Diego, CA: Academic Press.
3. Conley AJ, Mason JI. 1990 Placental steroidhormones. Baillière's Clin. Endocrinol. Metab. 4, 249-272. (doi:10.1016/s0950-351x(05)80050-3)
4. Carere C, Blathazart J. 2007 Sexual versus individual differentiation: the controversial role of avian maternal hormones. Trends Endocrinol. Metab. 18, 73-80. (doi:10.1016/j.tem.2007.01.003)
5. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, vom Saal FS. 2012 Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 153, 4097-4110. (doi:10.1210/en.2012-1422)
6. Gore AC. 2008 Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front. Neuroendocrinol. 29, 358-374. (doi:10.1016/j.yfrne.2008.02.002)
7. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. 2003 Large effects from small exposures. I. Mechanisms for endocrinedisrupting chemicals with estrogenic activity. Environ. Health Perspect. 111, 994-1006. (doi:10. 1289/ehp.5494)
8. Schug TT, Janesick A, Blumberg B, Heindel JJ. 2011 Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 127, 204-215. (doi:10.1016/j.jsbmb.2011.08.007)
9. Steinmetz R, Brown NG, Allen DL, Bigsby RM, BenJonathan N. 1997 The environmental estrogen bisphenol a stimulates prolactin release in vitro and in vivo. Endocrinology 138, 1780-1786. (doi:10. 1210/en.138.5.1780)
10. Kuiper G, Carlson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J. 1997 Comparison of ligand binding specificity and transcript tissues distribution of estrogen receptors a and b. Endocrinology 138, 863-870. (doi:10. 1210/en.138.3.863)
11. Kuiper G, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg P, Gustafsson JA. 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263. (doi:10.1210/en. 139.10.4252)
12. Nadal A, Alonso-Magdalena P, Ripoll C, Fuentas E. 2005 Disentangling the molecular mechanisms of action of endogenous and environmental estrogens. Pflugers Arch. 449, 335-343. (doi:10.1007/ s00424-004-1343-9)
13. Katzenellenbogen JA. 1995 The structural pervasiveness of estrogenic activity. Environ. Health Perspect. 103, 99-101. (doi:10.2307/3432517)
14. Mueller SO. 2004 Xenoestrogens: mechanisms of action and detection methods. Anal. Bioanal. Chem. 378, 582-587. (doi:10.1007/s00216-003-2238-x)
15. Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP, Gaido KW. 1998 Bisphenol A interacts with the estrogen receptor a in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142, 203-214. (doi:10.1016/S0303-7207(98)00084-7)
16. Matsushima A, Shimohigashi Y. 2008 A strategy to explore the target receptor of endocrine disruptors: estrogen-related receptor g (ERR g) as a genuine acceptor of bisphenol A. In Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences, 21-25 August 2007, Tokyo, Japan. AATEX 14, 495-497.
17. Chung E, Genco MC, Megrelis L, Ruderman JV. 2011 Effects of bisphenol A and triclocarban on brainspecific expression of aromatase in early zebrafish embryos. Proc. Natl Acad. Sci. USA 108, 17732-17737. (doi:10.1073/pnas.1115187108)
18. Kester MHA et al. 2002 Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J. Clin. Endocrinol. Metab. 87, 1142-1150. (doi:10.1210/jc.87.3.1142)
19. Harris RM, Wood DM, Bottomley L, Blagg S, Owen K, Hughes PJ, Waring RH, Kirk CJ. 2004 Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J. Clin. Endocrinol. Metab. 89, 1779-1787. (doi:10.1210/jc.2003-031631)
20. Diczfalusy E. 1964 Endocrine functions of human fetoplacental unit. Fed. Proc. 23, 791-798.
21. Dutton GJ. 1978 Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu. Rev. Pharmacol. Toxicol. 18, 17-35. (doi:10.1146/annurev.pa.18.040178. 000313)
22. Strott CA. 2002 Sulfonation and molecular action. Endocr. Rev. 23, 703-732. (doi:10.1210/er. 2001.0040)
23. Pasqualini JR, Gelly C, Lecerf F. 1986 Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 8, 233-240. (doi:10.1007/ bf01807336)
24. Paitz RT, Bowden RM. 2008 A proposed role of the sulfotransferase/sulfatase pathway in modulating yolk steroid effects. Integr. Comp. Biol. 48, 419-427. (doi:10.1093/icb/icn034)
25. Paitz RT, Bowden RM. 2009 Rapid decline in the concentrations of three yolk steroids during development: is it embryonic regulation? Gen. Comp. Endocrinol. 161, 246-251. (doi:10.1016/j. ygcen.2009.01.018)
26. Paitz RT, Bowden RM. 2011 Biological activity of oestradiol sulphate in an oviparous amniote: implications for maternal steroid effects. Proc. R. Soc. B 278, 2005-2010. (doi:10.1098/ rspb.2010.2128)
27. Paitz RT, Sawa AR, Bowden RM. 2012 Characterizing the metabolism and movement of yolk oestradiol during embryonic development in the redeared slider (Trachemys scripta). Gen. Comp. Endocrinol. 176, 507-512. (doi:10.1016/j.ygcen. 2011.10.009)
28. von Engelhardt N, Henriksen R, Groothuis TGG. 2009 Steroids in chicken egg yolk: metabolism and uptake during early embryonic development. Gen. Comp. Endocrinol. 163, 175-183. (doi:10.1016/j. ygcen.2009.04.004)
29. Paitz RT, Bowden RM, Casto JM. 2011 Embryonic modulation of maternal steroids in European starlings (Sturnus vulgaris). Proc. R. Soc. B 278, 99-106. (doi:10.1098/rspb.2010.0813)
30. Paitz RT, Casto JM. 2012 The decline in yolk progesterone concentrations during incubation is dependent on embryonic development in the European starling. Gen. Comp. Endocrinol. 176, 415-419. (doi:10.1016/j.ygcen.2011.12.014)
31. Paitz RT, Bowden RM. 2013 The sulfonation of maternal steroids is a conserved metabolic pathway in vertebrates. Integr. Comp. Biol. (doi:10.1093/icb/ict027)
32. Ekuase EJ, Liu Y, Lehmler HJ, Robertson LW, Duffel MW. 2011 Structure-activity relationships for hydroxylated polychlorinated biphenyls as inhibitors of the sulfation of dehydroepiandrosterone catalyzed by human hydroxysteroid sulfotransferase SULT2A1. Chem. Res. Toxicol. 24, 1720-1728. (doi:10.1021/tx200260h)
33. Wang LQ, Lehmler HJ, Robertson LW, James MO. 2006 Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate. Chem. Biol. Interact. 159, 235-246. (doi:10.1016/j.cbi.2005.12.004)
34. Xu CJ, Li CYT, Kong ANT. 2005 Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28, 249-268. (doi:10.1007/ BF02977789)
35. Talsness CE, Andrade AJM, Kuriyama SN, Taylor JA, vom Saal FS. 2009 Components of plastic: experimental studies in animals and relevance for human health. Phil. Trans. R. Soc. B 364, 2079-2096. (doi:10.1098/rstb.2008.0281)
36. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007 Human exposure to bisphenol A (BPA). Reprod. Toxicol. 24, 139-177. (doi:10.1016/ j.reprotox.2007.07.010)
37. Vandenberg LN, Chahoud I, Heindel J, Padmanabhan V, Paumgartten FJR, Schoenfelder G. 2010 Urinary circulating and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 118, 1055-1070. (doi:10.1289/ehp.0901716)
38. McLachlan JA. 2001 Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr. Rev. 22, 319-341. (doi:10.1210/er.22.3.319)
39. Welshons WV, Nagel SC, vom Saal FS. 2006 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147, S56-S69. (doi:10.1210/en.2005-1159)
40. Crain DA, Eriksen M, Iguchi T, Jobling S, Laufer H, LeBlanc GA, Guillette LJ. 2007 An ecological assessment of bisphenol-A: evidence from comparative biology. Reprod. Toxicol. 24, 225-239. (doi:10.1016/j.reprotox.2007.05.008)
41. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009 Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 30, 75-95. (doi:10.1210/er.2008-0021)
42. Matthews JB, Twomey K, Zacharewski TR. 2001 In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors a and b. Chem. Res. Toxicol. 14, 149-157. (doi:10.1021/tx0001833)
43. U.S. EPA. 2005 A cross-species mode of action information assessment: a case study of bisphenol-A (BPA) (EPA/600/R-50/044F). Washington, DC: US Environmental Protection Agency.
44. Hanoika N, Takeda Y, Tanaka-Kagawa T, Hayashi K, Jinno H, Narimatsu S. 2008 Interaction of bisphenol a with human UDP-glucuronosyltransferase 1a6 enzyme. Environ. Toxicol. 23, 407-412. (doi:10. 1002/tox.20345)
45. Fini J-B, Dolo L, Cravedi J-P, Demeneix B, Zalko D. 2009 Metabolism of the endocrine disruptor BPA by Xenopus laevis tadpoles. Ann. NY Acad. Sci. 1163, 394-397. (doi:10.1111/j.1749-6632.2008.03655.x)
46. Ewert MA, Legler JM. 1978 Hormonal induction of oviposition in turtles. Herpetologica 34, 314-318.
47. Les HL, Paitz RT, Bowden RM. 2007 Experimental test of the effects of fluctuating incubation temperatures on hatchling phenotype. J. Exp. Zool. 307A, 274-280. (doi:10.1002/jez.374)
48. Stoker C, Rodriguez H, Ramos JG, Sirosky P, Larriera A, Luque EH, Munoz-de-Toro M. 2003 Sex reversal effects on Caiman latirostris exposed to environmentally relevant doses of the xenoestrogen bisphenol A. Gen. Comp. Endocrinol. 133, 287-296. (doi:10.1016/S0016-6480(03)00199-0)
49. Wingfield JC, Farner DS. 1975 The determination of five steroids in avian plasma by radioimmunoassay and competitive protein binding. Steroids 26, 311-327. (doi:10.1016/0039-128X(75)90077-X)
50. Bowden RM, Ewert MA, Nelson CE. 2000 Environmental sex determination in a reptile varies seasonally and with yolk hormones. Proc. R. Soc. Lond. B 267, 1745-1749. (doi:10.1098/rspb.2000.1205)
51. Wang LQ, James MO. 2006 Inhibition of sulfotransferases by xenobiotics. Curr. Drug Metab. 7, 83-104. (doi:10.2174/138920006774832596)
52. Fry DM, Toone CK. 1981 DDT-induced feminization of gull embryos. Science 213, 922-924. (doi:10. 1126/science.7256288)
53. Anway MD, Skinner MK. 2006 Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147, S43-S49. (doi:10.1210/en. 2005-1058)
54. Howdeshell KL, vom Saal FS. 2000 Developmental exposure to bisphenol A: interaction with endogenous estradiol during pregnancy in mice. Am. Zool. 40, 429-437. (doi:10.1668/0003- 1569(2000)040[0429:DETBAI]2.0.CO;2)